Hester Biosciences share news, announcements and annual reports
NSE: HESTERBIOBSE: 524669Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,243.70.
29 Oct: open ₹2,243.70, high ₹2,333.10, low ₹2,223.00
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,963 Cr1,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 14.42
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹88 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 40.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 40.4%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹88 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 14.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.51
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,09656.3% delivered
Hester Biosciences has 502 announcements on record, routine notices left out; 4 in the 30 days to 29 Oct 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Hester Biosciences quarterly results
The board meets on 5 Nov 2026 to consider financial results
Notice filed 27 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Hester Biosciences annual reports, presentations and earnings calls
The company's own documents, latest first.Hester Biosciences financials, year by year
Annual reports12
- Annual report, year to Mar 202618 Jun 2026
- Annual report, year to Mar 202511 Jul 2025
- Annual report, year to Mar 202426 Jul 2024
- Annual report, year to Mar 202323 Aug 2023, a zip file
- Annual report, year to Mar 202229 Jul 2022, a zip file
7 earlier reports
- Annual report, year to Mar 202123 Jul 2021, a zip file
- Annual report, year to Mar 20204 Aug 2020, a zip file
- Annual report, year to Mar 20195 Jul 2019, a zip file
- Annual report, year to Mar 201811 Aug 2018, a zip file
- Annual report, year to Mar 201729 Jul 2017, a zip file
- Annual report, year to Mar 20164 Aug 2016, a zip file
- Annual report, year to Mar 201521 Aug 2015, a zip file
Investor presentations1
- Company's Presentation.28 May 2015, a zip file
Earnings calls44
- Transcript1 Aug 2026
- Link of Recording30 Jul 2026
- Transcript18 May 2026
- Link of Recording15 May 2026
- Transcript2 Feb 2026
39 earlier call documents
- Link of Recording30 Jan 2026
- Transcript14 Nov 2025
- Link of Recording12 Nov 2025
- Transcript4 Aug 2025
- Link of Recording1 Aug 2025
- Transcript12 May 2025
- Link of Recording9 May 2025
- Transcript1 Feb 2025
- Link of Recording30 Jan 2025
- Transcript30 Oct 2024
- Link of Recording28 Oct 2024
- Transcript5 Aug 2024
- Link of Recording2 Aug 2024
- Transcript14 May 2024
- Link of Recording10 May 2024
- Transcript5 Feb 2024
- Link of Recording2 Feb 2024
- Transcript9 Nov 2023
- Link of Recording7 Nov 2023
- Transcript16 Aug 2023
- Transcript22 May 2023
- Link of Recording18 May 2023
- Transcript2 Feb 2023
- Link of Recording31 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call7 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call4 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call23 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call10 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call26 May 2022
- Transcript2 Feb 2022
- Transcript9 Nov 2021
- Analysts/Institutional Investor Meet/Con. Call Updates - Correction in transcripts of earnings conference call1 Nov 2018
- Analysts/Institutional Investor Meet/Con. Call Updates: Transcript of Earnings Conference Call held by the Management of the Company with investors on 10 August 2018 at 2.30 p.m.13 Aug 2018, a zip file
- Analysts/Institutional Investor Meet/Con. Call Updates, Transcript of Earnings Conference Call held by the Management of the Company with investors on Tuesday, 23 January 2018 at 2.00 p.m. to discuss the Unaudited Standalone Financial Results for the quarter ended on 31 December 2017.25 Jan 2018, a zip file
- Analysts/Institutional Investor Meet/Con. Call Updates Submitted Transcripts of earnings conference call held on 9 November 201713 Nov 2017, a zip file
- Analysts/Institutional Investor Meet/Con. Call Updates: Submission of Transcripts of earnings conference call held on 8 May 2017 at 2.00 p.m.10 May 2017, a zip file
- Analysts/Institutional Investor Meet/Con. Call Updates Submission of Transcript of Earnings Conference Call dated 19 January 201720 Jan 2017, a zip file
- Transcript of Earnings Conference Call22 Oct 2016, a zip file
- Transcript of Earnings Conference Call held by the Management of the Company with investors on August 01, 2016 to discuss the financial results of the Company for the quarter ended on June 30, 2016.3 Aug 2016, a zip file
Hester Biosciences merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Hester Biosciences share news and announcements
Newest first. Page 1 of 11.
Oct 2026
28 Oct · Analysts
27 Oct · Board meeting
Sep 2026
Aug 2026
27 Aug · Rating
4 Aug · Meeting
Jul 2026
31 Jul
30 Jul · Results
25 Jul · Analysts
23 Jul · Board meeting
8 Jul · Corrigendum
Jun 2026
18 Jun · Corporate action
18 Jun · Meeting
May 2026
20 May
15 May
15 May
15 May · Results
12 May · Management
11 May · Analysts
8 May · Board meeting
Board Meeting to be held on 15-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
Apr 2026
Mar 2026
20 Mar · Rating
Feb 2026
4 Feb · Meeting
Jan 2026
30 Jan · Results
23 Jan · Analysts
21 Jan · Board meeting
Nov 2025
12 Nov
12 Nov · Results
12 Nov · Board meeting
5 Nov · Analysts
4 Nov · Board meeting
Not held on this date
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 27 Oct 2026Board or managers changedup 4.61%+4.0 pts vs Nifty 500market median 0.0% · volume 0.5× usual · delivery −14.9 pts against usual · The announcement
- 28 Aug 2026Credit ratingup 0.55%+0.3 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−2.9 pts vs Nifty 500) · volume 0.4× usual · delivery +0.6 pts against usual · The announcement
- 30 Jul 2026Resultsdown 0.75%−0.8 pts vs Nifty 500market median −0.7% · five sessions −2.5% (−4.2 pts vs Nifty 500) · volume 8.2× usual · delivery −38.9 pts against usual · The announcement
- 15 May 2026Resultsup 5.24%+5.6 pts vs Nifty 500market median −0.7% · five sessions +8.1% (+8.2 pts vs Nifty 500) · volume 25.8× usual · delivery −39.1 pts against usual · The announcement
- 13 May 2026Board or managers changedup 0.72%+0.4 pts vs Nifty 500market median 0.0% · five sessions +6.0% (+5.0 pts vs Nifty 500) · volume 0.5× usual · delivery −13.8 pts against usual · The announcement
- 20 Mar 2026Credit ratingdown 1.96%−2.4 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−6.4 pts vs Nifty 500) · volume 0.9× usual · delivery −3.3 pts against usual · The announcement
- 30 Jan 2026Resultsup 3.05%+3.3 pts vs Nifty 500market median −0.7% · five sessions +6.1% (+4.3 pts vs Nifty 500) · volume 4.9× usual · delivery −27.3 pts against usual · The announcement
- 14 Nov 2025Board or managers changeddown 1.64%−1.7 pts vs Nifty 500market median 0.0% · five sessions −0.7% (−1.4 pts vs Nifty 500) · volume 1.0× usual · delivery +18.9 pts against usual · The announcement
- 12 Nov 2025Resultsup 2.66%+2.0 pts vs Nifty 500market median −0.7% · five sessions +2.9% (+2.3 pts vs Nifty 500) · volume 11.9× usual · delivery −53.9 pts against usual · The announcement
- 1 Aug 2025Resultsup 12.55%+13.6 pts vs Nifty 500market median −0.7% · five sessions +3.1% (+4.1 pts vs Nifty 500) · volume 84.7× usual · delivery −45.8 pts against usual · The announcement
20 earlier announcements
- 9 May 2025Dividenddown 2.52%−1.8 pts vs Nifty 500market median 0.0% · five sessions +6.8% (+2.5 pts vs Nifty 500) · volume 1.9× usual · delivery −17.9 pts against usual · The announcement
- 9 May 2025Resultsdown 2.52%−1.8 pts vs Nifty 500market median −0.7% · five sessions +6.8% (+2.5 pts vs Nifty 500) · volume 1.9× usual · delivery −17.9 pts against usual · The announcement
- 30 Jan 2025Resultsdown 2.35%−2.6 pts vs Nifty 500market median −0.7% · five sessions −9.1% (−11.4 pts vs Nifty 500) · volume 4.4× usual · delivery −40.4 pts against usual · The announcement
- 24 Dec 2024Board or managers changedup 0.92%+1.0 pts vs Nifty 500market median 0.0% · five sessions +0.7% (+0.9 pts vs Nifty 500) · volume 0.3× usual · delivery −2.7 pts against usual · The announcement
- 20 Dec 2024Credit ratingdown 1.43%+0.5 pts vs Nifty 500market median 0.0% · five sessions −0.3% (+1.0 pts vs Nifty 500) · volume 0.5× usual · delivery −1.8 pts against usual · The announcement
- 31 Oct 2024Board or managers changeddown 1.24%−1.0 pts vs Nifty 500market median 0.0% · five sessions +2.1% (+0.9 pts vs Nifty 500) · volume 0.4× usual · delivery −6.7 pts against usual · The announcement
- 28 Oct 2024Resultsup 6.14%+5.5 pts vs Nifty 500market median −0.7% · five sessions +7.3% (+5.8 pts vs Nifty 500) · volume 13.0× usual · delivery −48.7 pts against usual · The announcement
- 2 Aug 2024Resultsdown 1.05%0.0 pts vs Nifty 500market median −0.7% · five sessions −14.1% (−10.7 pts vs Nifty 500) · volume 1.7× usual · delivery −21.0 pts against usual · The announcement
- 10 May 2024Dividendup 4.59%+4.0 pts vs Nifty 500market median 0.0% · five sessions +7.2% (+4.4 pts vs Nifty 500) · volume 12.0× usual · delivery −51.4 pts against usual · The announcement
- 1 Mar 2024Board or managers changedup 2.06%+0.8 pts vs Nifty 500market median 0.0% · five sessions +0.8% (−0.7 pts vs Nifty 500) · volume 0.6× usual · delivery −15.7 pts against usual · The announcement
- 2 Feb 2024Resultsdown 3.89%−4.6 pts vs Nifty 500market median −0.7% · five sessions −7.2% (−8.3 pts vs Nifty 500) · volume 3.7× usual · delivery −18.5 pts against usual · The announcement
- 2 Jan 2024Credit ratingup 0.49%+0.8 pts vs Nifty 500market median 0.0% · five sessions +8.4% (+8.7 pts vs Nifty 500) · volume 2.6× usual · delivery −15.7 pts against usual · The announcement
- 7 Nov 2023Resultsdown 3.03%−3.2 pts vs Nifty 500market median −0.7% · five sessions −6.1% (−7.3 pts vs Nifty 500) · volume 4.2× usual · delivery −37.0 pts against usual · The announcement
- 3 Jul 2023Credit ratingdown 0.64%−1.2 pts vs Nifty 500market median 0.0% · five sessions −0.6% (−1.4 pts vs Nifty 500) · volume 0.7× usual · delivery −13.2 pts against usual · The announcement
- 17 May 2023Dividenddown 6.03%−5.6 pts vs Nifty 500market median 0.0% · five sessions −8.0% (−8.3 pts vs Nifty 500) · volume 7.4× usual · delivery −46.9 pts against usual · The announcement
- 27 Mar 2023Board or managers changeddown 1.62%−1.5 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−2.3 pts vs Nifty 500) · volume 0.6× usual · delivery −4.1 pts against usual · The announcement
- 8 Feb 2023Credit ratingdown 2.66%−3.5 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−2.5 pts vs Nifty 500) · volume 1.3× usual · delivery +9.9 pts against usual · The announcement
- 10 Aug 2022Resultsdown 6.30%−6.2 pts vs Nifty 500market median −0.7% · five sessions −12.0% (−14.5 pts vs Nifty 500) · volume 12.2× usual · delivery −37.5 pts against usual · The announcement
- 20 May 2022Dividenddown 2.26%−4.8 pts vs Nifty 500market median 0.0% · five sessions −6.4% (−7.6 pts vs Nifty 500) · volume 3.9× usual · delivery −27.0 pts against usual · The announcement
- 31 Jan 2022Resultsup 4.74%+3.4 pts vs Nifty 500market median −0.7% · five sessions +3.4% (+1.0 pts vs Nifty 500) · volume 10.2× usual · delivery −39.6 pts against usual · The announcement
Hester Biosciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.